Katrin Rupalla

449 total citations
9 papers, 370 citations indexed

About

Katrin Rupalla is a scholar working on Neurology, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, Katrin Rupalla has authored 9 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Economics and Econometrics. Recurrent topics in Katrin Rupalla's work include Cancer Genomics and Diagnostics (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Katrin Rupalla is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Katrin Rupalla collaborates with scholars based in Germany, Switzerland and Sweden. Katrin Rupalla's co-authors include Dirk Sauer, Peter R. Allegrini, Christoph Wießner, Josef Krieglstein, Weihong Cao, Matthias Welsch, Petra Henrich‐Noack, Hanan S. El‐Abhar, Serge Bischoff and Ailsa L. McGregor and has published in prestigious journals such as European Journal of Pharmacology, European Journal of Cancer and Acta Neuropathologica.

In The Last Decade

Katrin Rupalla

8 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katrin Rupalla Germany	5	180	138	90	68	63	9	370
Jiezhong Yu China	7	146 0.8×	161 1.2×	54 0.6×	16 0.2×	119 1.9×	16	386
Jiaojiang He China	11	54 0.3×	171 1.2×	86 1.0×	23 0.3×	52 0.8×	22	363
Marios Kritsilis Sweden	5	93 0.5×	137 1.0×	57 0.6×	13 0.2×	149 2.4×	5	368
K. Czeloth Germany	4	125 0.7×	189 1.4×	40 0.4×	17 0.3×	51 0.8×	8	414
Junya Hamanaka Japan	8	219 1.2×	131 0.9×	37 0.4×	17 0.3×	44 0.7×	10	419
Dezhen Tu China	9	148 0.8×	160 1.2×	45 0.5×	10 0.1×	68 1.1×	11	384
Yoshinori Toshima Japan	11	83 0.5×	139 1.0×	117 1.3×	13 0.2×	58 0.9×	14	374
M.T. Domingo France	7	91 0.5×	158 1.1×	93 1.0×	30 0.4×	82 1.3×	9	349
Yunsi Yin China	9	197 1.1×	97 0.7×	26 0.3×	20 0.3×	124 2.0×	20	379

Countries citing papers authored by Katrin Rupalla

Since Specialization

Citations

This map shows the geographic impact of Katrin Rupalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Rupalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Rupalla more than expected).

Fields of papers citing papers by Katrin Rupalla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Rupalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Rupalla. The network helps show where Katrin Rupalla may publish in the future.

Co-authorship network of co-authors of Katrin Rupalla

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Rupalla. A scholar is included among the top collaborators of Katrin Rupalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Rupalla. Katrin Rupalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Glasmacher, Axel, Elena Garralda, Chad Gwaltney, et al.. (2025). Dose optimization in cancer drug development: Review and outcome of a multi-stakeholder workshop. European Journal of Cancer. 226. 115593–115593. 1 indexed citations

Rupalla, Katrin, et al.. (2024). The Tango to Modern Collaboration and Patient-Centric Value Generation in Health Care – a real-world guide from practitioners for practitioners. Current Medical Research and Opinion. 41(1). 31–41.

Onakpoya, Igho, et al.. (2022). International oncology drug approvals for multiregional or single-country clinical trials: A systematic review. Frontiers in Medicine. 9. 1084980–1084980. 1 indexed citations

Janicot, Michel, Katrin Rupalla, Alexej Schmidt, Iris Helfrich, & Bernhard B. Singer. (2022). 1384 Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy and significantly increases B-cell response in syngeneic liver Hepa1-6 tumor microenvironment. Regular and Young Investigator Award Abstracts. A1438–A1438. 1 indexed citations

Bajaj, Gaurav, Manish Gupta, Jeffrey S. Barrett, et al.. (2018). Challenges and Opportunities With Oncology Drug Development in China. Clinical Pharmacology & Therapeutics. 105(2). 363–375. 23 indexed citations

Wießner, Christoph, Peter R. Allegrini, Katrin Rupalla, et al.. (1999). Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice. Neuroscience Letters. 268(3). 119–122. 82 indexed citations

Rupalla, Katrin, Peter R. Allegrini, Dirk Sauer, & Christoph Wießner. (1998). Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice. Acta Neuropathologica. 96(2). 172–178. 135 indexed citations

Rupalla, Katrin, Weihong Cao, & Josef Krieglstein. (1995). Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration. European Journal of Pharmacology. 294(2-3). 469–473. 47 indexed citations

Krieglstein, Josef, et al.. (1995). Neuroprotective effects of Ginkgo biloba constituents. European Journal of Pharmaceutical Sciences. 3(1). 39–48. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact